Ionis Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
Well, great. Hello, everybody, and thank you for dialing in. My name is Luca Issi. I'm a senior biotech analyst here at RBC Capital Markets. And today is our great privilege to have Beth Hougen, the CFO of Ionis for a fireside chat. Thanks so much for joining us. How are you doing today?
Great. Thanks for having this, Luca. I appreciate it.
Questions & Answers
That's fantastic. So can you maybe start with a question on Akcea. You obviously recently completed the acquisition of Akcea. Can you remind us the rationale behind that decision? And maybe just give us a quick update on the process? And how should we think about cost synergies going forward here?
Sure.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
